Jun Amaki
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
Papers in
-
- Acute Myeloid Leukemia Research 2
- Hematopoietic Stem Cell Transplantation 2
- Hemophilia Treatment and Research 1
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Kiyoshi Ando (18 shared papers)Minoru Kojima (9 shared papers)Hiroshi Kawada (11 shared papers)Yoshiaki Ogawa (10 shared papers)Naoya Nakamura (8 shared papers)Ryujiro Hara (7 shared papers)Shinichiro Machida (12 shared papers)Makoto Onizuka (12 shared papers)
- Journals
- International Journal of Hematology (5 papers)Journal of the Japan Society of the Reticuloendothelial System (2 papers)Cancer Science (2 papers)Annals of Hematology (2 papers)Hematological Oncology (1 paper)
- Partner nations
- JapanSouth Korea
In The Last Decade
Jun Amaki
23 papers receiving 335 citations
Peers
Comparison fields: 5 of 33
- Pathology and Forensic Medicine 179
- Oncology 132
- Hematology 43
- Pharmacology 9
- Neurology 12
Countries citing papers authored by Jun Amaki
This map shows the geographic impact of Jun Amaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Amaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Amaki more than expected).
Fields of papers citing papers by Jun Amaki
This network shows the impact of papers produced by Jun Amaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Amaki. The network helps show where Jun Amaki may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Amaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 129 | |
| 2 | 2014 | 63 | |
| 3 | 2017 | 34 | |
| 4 | 2015 | 18 | |
| 5 | 2018 | 18 | |
| 6 | 2019 | 18 | |
| 7 | 2017 | 11 | |
| 8 | 2016 | 8 | |
| 9 | 2012 | 7 | |
| 10 | 2018 | 6 | |
| 11 | 2013 | 5 | |
| 12 | 2015 | 5 | |
| 13 | 2016 | 4 | |
| 14 | 2013 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2016 | 1 |
About Jun Amaki
Jun Amaki is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Neurology and Immunology, having authored 25 papers that have together received 342 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (5 papers), Acute Myeloid Leukemia Research (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Hemophilia Treatment and Research (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (179 citations), Oncology (132 citations), Hematology (43 citations), Pharmacology (9 citations) and Neurology (12 citations). Jun Amaki has collaborated with scholars based in Japan and South Korea. Frequent co-authors include Kiyoshi Ando, Minoru Kojima, Hiroshi Kawada, Yoshiaki Ogawa, Naoya Nakamura, Ryujiro Hara, Shinichiro Machida, Makoto Onizuka, Ai Sato and Ken Ohmachi. Their work appears in journals such as International Journal of Hematology, Journal of the Japan Society of the Reticuloendothelial System, Cancer Science, Annals of Hematology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.